Thousands of people in Britain are dealing with a enigmatic and incapacitating dermatological condition that has stumped doctors. Sufferers report their skin becoming badly inflamed, cracked and flaking, often across their entire bodies, yet many doctors find it difficult to diagnose and treat the condition. The condition, known as topical steroid withdrawal (TSW) or red skin syndrome, has generated significant attention on online platforms, with clips featuring patients’ experiences accumulating over one billion views on TikTok alone. Although it affects a growing number of people, TSW is so little understood that some general practitioners and dermatologists question whether it exists at all. Now, for the first time, researchers in the UK are undertaking a large-scale study to investigate what is behind these mysterious symptoms and reasons why some people develop the condition whilst others do not.
The Puzzling Ailment Sweeping Across the UK
Bethany Gamble’s case exemplifies the devastating impact of topical steroid withdrawal on patients’ wellbeing. The 21-year-old from Birmingham had managed her eczema well with steroid creams since childhood, but at eighteen, her condition worsened considerably. Her skin became severely inflamed and reddened, cracking and oozing whilst the itching became what she characterises as “bone deep”. Within two years, the pain had become so intense that she was stuck in her bed, dependent on continuous support from her mother. Most concerning, Bethany experienced repeated dismissal by medical professionals who blamed her symptoms on standard eczema and continued prescribing the very treatments she believed were causing her suffering.
The medical community is split on how to approach TSW, with fundamental disagreement about its very nature. Some experts view it as a severe allergic response to the topical steroids that represent the standard treatment for eczema across the NHS. Others contend it amounts to a serious exacerbation of current skin conditions rather than a unique syndrome, whilst a handful doubt of its existence altogether. This professional uncertainty has placed patients like Bethany caught in a diagnostic limbo, having difficulty accessing proper treatment. The failure to reach consensus has encouraged Professor Sara Brown at the Edinburgh University to set up the inaugural major UK research project studying TSW, funded by the National Eczema Society.
- Symptoms comprise significant swelling, skin fissuring and intense itching across the body
- Patients describe “elephant skin” thickening and excessive flaking of dead skin cells
- Healthcare practitioners commonly disregard TSW as typical dermatitis or refuse to acknowledge it
- The condition may become so debilitating that sufferers find themselves unable to carry out everyday tasks
Living with Steroid Topical Withdrawal
From Mild Eczema to Severe Symptoms
For numerous sufferers, topical steroid withdrawal constitutes a catastrophic deterioration from a formerly stable skin condition. What starts with intermittent itching in skin creases can quickly progress into a full-body inflammatory response that leaves patients incapable of functioning. The change typically happens suddenly, without warning, transforming a controllable long-term condition into an severe medical emergency. Patients report their skin turning intensely hot, red and inflamed, with severe cracking and oozing that requires ongoing care. The bodily burden is worsened by exhaustion, as the persistent itching disrupts sleep and healing, establishing a destructive cycle of decline.
The pace at which TSW develops catches many sufferers by surprise. Those who have dealt with eczema for years, sometimes decades, are unprepared for the severity of symptoms that appear when their condition rapidly deteriorates. Routine activities become monumental challenges: showering becomes agonising, dressing demands help, and maintaining personal hygiene demands enormous effort. Some patients describe feeling as though their skin is being ravaged from within, with inflammation spreading across their body in patterns that show little similarity to their previous eczema flare-ups. This marked shift often prompts sufferers to seek urgent medical help, only to meet with doubt from healthcare professionals.
The Push for Recognition
Perhaps the most distressing aspect of topical steroid withdrawal is the medical gaslighting that commonly occurs with it. Patients experiencing severe, unexplained symptoms are consistently informed they merely suffer from eczema worsening, despite their insistence that this is fundamentally different from anything they’ve encountered previously. Doctors often respond by prescribing stronger steroids or increased doses, possibly exacerbating the very condition patients believe the creams caused. This pattern of rejection leaves sufferers experiencing abandonment by the healthcare system, compelled to manage their illness alone whilst being informed that their personal experience lacks validity. Many patients report experiencing repeated invalidation, their concerns dismissed as anxiety or psychological rather than genuine physiological symptoms.
The lack of professional agreement has created a dangerous gap between what patients report and professional recognition. Without clear diagnostic criteria or defined treatment approaches, general practitioners and skin specialists find it difficult to diagnose TSW or offer appropriate support. Some practitioners remain completely sceptical the condition exists, treating all severe presentations as standard eczema or recognised skin disorders. This clinical doubt results in delayed diagnosis, inappropriate treatment and significant emotional suffering for people experiencing physical symptoms. The increased prominence of TSW on social media has drawn attention to this diagnostic void, encouraging investigation to investigate what thousands of people claim to be experiencing, even as the healthcare profession remains divided on the appropriate response.
- Symptoms can emerge suddenly in individuals with previously stable eczema treated by topical steroids
- Patients often face disbelief from medical practitioners who ascribe deterioration to typical eczema exacerbations
- Healthcare providers continue to disagree on whether TSW is a real disorder or severe eczema exacerbation
- Absence of established diagnostic standards means numerous patients struggle to access appropriate treatment and support
- Online platforms has amplified patient voices, with TSW hashtags reaching more than one billion views worldwide
Racial Disparities in Assessment and Clinical Management
The diagnostic challenges surrounding TSW become increasingly evident amongst individuals with darker skin, where symptoms can be considerably more difficult to recognise visually. Redness and inflammation, the characteristic indicators of TSW in lighter-skinned individuals, appear differently across multiple populations, yet many diagnostic frameworks remain centred on how the condition appears in white patients. This difference means that Black, Asian and other people of colour experiencing TSW commonly experience substantially longer periods in identification and acceptance. Healthcare professionals trained mainly through appearances in lighter skin types may overlook or misinterpret the characteristic signs, resulting in continued misidentification and unsuitable therapeutic suggestions that can exacerbate suffering.
Research into TSW has historically overlooked the experiences of people with deeper skin tones, sustaining a pattern where their condition goes under-documented and under-studied. The online discussions shaping TSW discourse have been largely shaped by voices with lighter skin, risking distortion of clinical knowledge and community understanding. As Professor Sara Brown’s pioneering British research advances, guaranteeing inclusive participation amongst research participants will be crucial to developing truly inclusive diagnostic criteria and treatment approaches. Without deliberate efforts to prioritise the perspectives of all ethnic groups, healthcare disparities in TSW recognition and management risk widening further, abandoning at-risk communities without adequate support or answers.
| Skin Tone | TSW Appearance |
|---|---|
| Light/Fair | Bright red inflammation, visible flushing and erythema across affected areas |
| Medium/Olive | Darker red or brownish discolouration with less pronounced visible redness |
| Dark/Deep | Purple-toned or ashen discolouration, with inflammation appearing as hyperpigmentation or hypopigmentation |
| Very Dark | Subtle changes in skin texture and tone, with inflammation manifesting as dark patches or loss of pigmentation |
Emerging Research and Care Approaches Emerging
First Major UK Investigation Currently Happening
Professor Sara Brown’s landmark research at the University of Edinburgh constitutes a turning point for TSW sufferers seeking validation and understanding. With backing from the National Eczema Society, the study has brought together many participants across the UK to explore the biological mechanisms underlying topical steroid withdrawal. By examining symptoms, saliva samples and skin biopsies, researchers seek to identify why particular individuals experience TSW whilst others on identical steroid regimens do not. This scientific scrutiny marks a significant shift from dismissal to thorough inquiry.
The investigative group working alongside Dr Alice Burleigh from patient advocacy group Scratch That, brings both clinical knowledge and lived experience to the investigation. Their partnership approach acknowledges that people with the condition hold crucial insights into their health situations. Professor Brown has identified patterns in TSW that defy explanation by traditional understanding of eczema, including distinctive “elephant skin” thickening, pronounced shedding and sharply demarcated inflammatory patches. The study’s findings could significantly transform how medical professionals approach diagnosis and management of this disabling illness.
Available Treatments and Associated Limitations
Currently, management options for TSW remain limited and commonly disappointing. Many healthcare professionals persist in prescribing topical steroids despite clear evidence implying they might intensify symptoms in those predisposed. Some patients report temporary relief from emollients, antihistamines and systemic medications, though responses vary considerably. Dermatologists continue to disagree on best treatment approaches, with some recommending full steroid withdrawal whilst others advocate phased withdrawal. This lack of consensus forces patients to navigate their therapeutic pathways mostly in isolation, drawing substantially on peer support networks and web-based forums for guidance.
Psychological support and specialist dermatological care may provide advantages, yet access remains patchy across the NHS. Some patients have investigated complementary methods including dietary modifications, environmental controls and holistic therapies, though scientific evidence supporting these interventions is limited. The lack of established clinical protocols means treatment decisions often depend on individual dermatologist experience and patient preference rather than evidence-based guidelines. Until robust research produces definitive answers, TSW sufferers frequently describe experiencing abandonment by conventional medicine.
- Emollients and moisturisers to enhance skin barrier function and decrease water loss
- Antihistamines to alleviate itching and related sleep disturbance in flare episodes
- Oral corticosteroids or immunosuppressants for serious presentations under specialist supervision
- Psychological counselling to tackle trauma and anxiety stemming from prolonged skin suffering
Testimonies of Aspiration and Perseverance
Despite the uncertainty surrounding TSW and the often dismissive attitudes from healthcare professionals, patients are drawing strength in shared community and shared experience. Digital support communities have become lifelines for those struggling with the disorder, providing validation and practical advice when conventional medicine has let them down. Many individuals affected recount the moment they discovered the TSW hashtag as transformative—finally connecting with others with the same symptoms and realising they were not isolated in their suffering. This collective voice has been powerful enough to trigger the first serious research efforts, demonstrating that patient advocacy can drive medical progress even when institutional structures stay unconvinced.
Bethany Gamble and people in similar situations are resolved to increase visibility and campaign for due recognition of TSW within the medical community. Their readiness to discuss intimate experiences of their struggles on online platforms has normalised conversations around a condition that various medical professionals still are unwilling to accept. These patients are not sitting idly for answers; they are actively participating in research studies, tracking their signs thoroughly, and requiring that their accounts be given proper consideration. Their resilience in the midst of ongoing pain and invalidating medical treatment provides encouragement that solutions could become within attainment, and that future patients will obtain the acknowledgement and treatment they so desperately need.
- Patient-led research initiatives are addressing shortcomings left by traditional medical institutions and advancing knowledge of TSW
- Online communities provide emotional support, actionable management techniques, and mutual recognition for isolated sufferers globally
- Campaign work are gradually shifting clinical attitudes, encouraging dermatologists to examine rather than overlook individual accounts
